Alantra has acted as sole financial advisor to Luxempart S.A., a Luxembourg-based listed investment company, on its partnership with VALEARA, a leading provider of ambulatory mental healthcare services in Germany. Luxempart will acquire a majority stake in the company, partnering with VALEARA’s existing shareholders led by private investment firm GENUI, as well as the group’s management headed by Dr. Christian Utler (CEO). The transaction is expected to close in the first quarter of 2026.
VALEARA plays a vital role in improving access to mental healthcare in Germany. Through an integrated platform of different care settings and interdisciplinary teams, the company offers timely, comprehensive and high-quality treatment for patients in need. Furthermore, it addresses a structural undersupply of therapeutic capacity through its own in-house academy. Headquartered in Germany and founded in 1983 (originally as ZNS), VALEARA operates seven primarily outpatient clinics across 14 locations and employs approximately 700 professionals.
As new majority investor, Luxempart will support VALEARA through its next phase of growth while preserving the company’s strong culture and focus on patient outcomes.
Christopher Jobst, Managing Director at Alantra, said: “VALEARA is an exceptional business in a vital area of healthcare, and this transaction creates a highly compelling partnership for long-term growth. It has been a pleasure to support Luxempart throughout this process, and we look forward to seeing VALEARA continue its impressive development.”
This transaction adds to Alantra’s strong global track record in the healthcare space, which includes advising Oakley Capital on the strategic combination of Windstar Medical and Merz Group, Affidea on its acquisition of Uroviva, Orphelia Pharma on its sale to Orphalan, and emeis on the divestment of Senevita to Tertianum.
cloud technology axon
Since Suma Capital’s entry in 2020, Gestcompost has quadrupled its E...
